Abstract
Background: Hepatitis B virus claims approximately 780000 human lives each year. Inadequate effectiveness and drug resistance has led to the search for more potent antivirals with minimal risk of resistance. Plant extract from Phyllanthus genus have long been used in traditional medicine as effective antiviral and hepatoprotective agents.
Objective: The present study aims to find the active principle of Phyllanthus and their mode of action against Hepatitis B Virus Reverse Transcriptase (HBV RT), a potential drug target of HBV infection. Methods: The 3D structure of HBV RT was modeled and its stability was assessed with a 50ns molecular dynamics simulation. Ninety-three phytochemicals were screened from Phyllanthus and used for docking study taking lamivudine as control drug. Results: Comparison of binding energy suggests that, lupeol acetate, a triterpene of P. niruri, P. reticulatus and P. urinaria showed highest binding energy for both native and M204V mutated HBV RT (-7.95 kcal/mol & -6.16 kcal/mol respectively) than the control drug lamivudine (-4.57 kcal/mol & -3.50 kcal/mol respectively). Subsequently, lupeol acetate was screened for in silico ADME/Tox property and result indicates good bioavailability without toxicity and can be treated as a candidate drug molecule. Conclusion: Further clinical testing may lead to the discovery of a novel HBV RT inhibitor.Keywords: Phyllanthus, lupeol acetate, Hepatitis B virus, molecular docking, molecular dynamics simulation, in silico ADME/Tox and Lamivudine.
The Natural Products Journal
Title:In Silico Identification of Natural Lead Molecules from the Genus of Phyllanthus Against Hepatitis B Virus Reverse Transcriptase
Volume: 6 Issue: 4
Author(s): Kishore Sarma, Biswajyoti Borkakoty, Pratap Parida, Aniruddha Jakharia, Dipankar Dey, Dipankar Biswas, Debashis Panda, Mahendra K. Modi, Pradyumna K. Mohapatra and Jagadish Mahanta
Affiliation:
Keywords: Phyllanthus, lupeol acetate, Hepatitis B virus, molecular docking, molecular dynamics simulation, in silico ADME/Tox and Lamivudine.
Abstract: Background: Hepatitis B virus claims approximately 780000 human lives each year. Inadequate effectiveness and drug resistance has led to the search for more potent antivirals with minimal risk of resistance. Plant extract from Phyllanthus genus have long been used in traditional medicine as effective antiviral and hepatoprotective agents.
Objective: The present study aims to find the active principle of Phyllanthus and their mode of action against Hepatitis B Virus Reverse Transcriptase (HBV RT), a potential drug target of HBV infection. Methods: The 3D structure of HBV RT was modeled and its stability was assessed with a 50ns molecular dynamics simulation. Ninety-three phytochemicals were screened from Phyllanthus and used for docking study taking lamivudine as control drug. Results: Comparison of binding energy suggests that, lupeol acetate, a triterpene of P. niruri, P. reticulatus and P. urinaria showed highest binding energy for both native and M204V mutated HBV RT (-7.95 kcal/mol & -6.16 kcal/mol respectively) than the control drug lamivudine (-4.57 kcal/mol & -3.50 kcal/mol respectively). Subsequently, lupeol acetate was screened for in silico ADME/Tox property and result indicates good bioavailability without toxicity and can be treated as a candidate drug molecule. Conclusion: Further clinical testing may lead to the discovery of a novel HBV RT inhibitor.Export Options
About this article
Cite this article as:
Sarma Kishore, Borkakoty Biswajyoti, Parida Pratap, Jakharia Aniruddha, Dey Dipankar, Biswas Dipankar, Panda Debashis, Modi K. Mahendra, Mohapatra K. Pradyumna and Mahanta Jagadish, In Silico Identification of Natural Lead Molecules from the Genus of Phyllanthus Against Hepatitis B Virus Reverse Transcriptase, The Natural Products Journal 2016; 6 (4) . https://dx.doi.org/10.2174/2210315506666160822095818
DOI https://dx.doi.org/10.2174/2210315506666160822095818 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ribonucleotide Reductase: A Critical Enzyme for Cancer Chemotherapy and Antiviral Agents
Recent Patents on Anti-Cancer Drug Discovery Cellular Delivery In Vivo of siRNA-Based Therapeutics
Current Pharmaceutical Design Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Interaction of Biologically Active Amines with Mitochondria and Their Role in the Mitochondrial-Mediated Pathway of Apoptosis
Current Medicinal Chemistry Nanomaterials for Photohyperthermia: A Review
Current Pharmaceutical Design Clinical Trials of Targeted Alpha Therapy for Cancer
Reviews on Recent Clinical Trials Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China
Current Gene Therapy Glycosidated Phospholipids – a Promising Group of Anti-Tumour Lipids
Anti-Cancer Agents in Medicinal Chemistry CXCR4 and Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Computational Approaches for Fragment-Based and De Novo Design
Current Topics in Medicinal Chemistry Role of Diet and Nutrition on the Alteration of the Quality and Quantity of Stem Cells in Human Aging and the Diseases of Aging
Current Pharmaceutical Design Vasoproliferation and Antiproliferative Treatment Options in Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery Insights into the Structural Features Essential for JAK2 Inhibition and Selectivity
Current Medicinal Chemistry Design, Synthesis and Biochemical Evaluation of Estrogen Receptor Ligand Conjugates as Tumour Targeting Agents
Letters in Drug Design & Discovery A Review of PCSK9 Inhibitors and their Effects on Cardiovascular Diseases
Current Topics in Medicinal Chemistry Patent Analysis as a Tool for Research Planning: Study on Natural Based Therapeutics Against Cancer Stem Cells
Recent Patents on Anti-Cancer Drug Discovery Pyrrolizidine Alkaloids and their Biological Properties from Indian Heliotropium Species
Current Bioactive Compounds Angiomodulatory and Neurological Effects of Ginsenosides
Current Medicinal Chemistry Polo-Like Kinases Inhibitors
Current Medicinal Chemistry Retinoid Receptors in Inflammatory Responses: A Potential Target for Pharmacology
Current Drug Targets - Inflammation & Allergy